N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate salt
IDENTITY
CAS Number:
145202-66-0
MDL Number:
MFCD00866224
MF:
C22H25N5O2
MW:
391.47
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:
98% (HPLC), powder
Physical Form (at 20°C):
Solid
Melting Point:
175-184°C
Long-Term Storage:
Store long-term in a cool, dry place
DOT/IATA TRANSPORT INFORMATION
Not hazardous material
BIOLOGICAL INFO
Solubility:
DMSO: 20mg/mL; H2O: 46mg/mL; EtOH: <1mg/mL
Application(s):
5-HT1 agonist
Form:
Benzoate salt
REVIEW A serotonin 5-HT1 agonist triptan drug for the treatment of migraine headaches.
REFERENCES
[1]
Ho TW, Pearlman E, Lewis D, Hämäläinen M, Connor K, Michelson D, Zhang Y, Assaid C, Mozley LH, Strickler N, Bachman R, Mahoney E, Lines C, Hewitt DJ; Rizatriptan Protocol 082 Pediatric Migraine Study Group (2012). Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 32(10):750-65. PMID 22711898.
[2]
Müller T, Lohse L (2011). Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacks. Clin Neuropharmacol. 34(6):206-9. PMID 21996647.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.
Add to Favorites 
Delete from Favorites 
